Matija Rijavec | Genetics | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Matija Rijavec | Genetics | Best Researcher Award

Assist Prof Dr . Matija Rijavec | Genetics | Best Researcher Award

Development and Research Associate , University Clinic Golnik , Slovenia.

Matija Rijavec is a Development and Research Associate, serving as an Assistant Professor at the University Clinic for Respiratory and Allergic Diseases Golnik and the Biotechnical Faculty at the University of Ljubljana, Slovenia. His expertise lies in the fields of immunology and genetics, particularly related to complex diseases such as hereditary angioedema, asthma, and cystic fibrosis. Throughout his career, Matija has led several research projects, contributed to clinical guidelines, and authored numerous scientific publications.

Profile

ORCiD

Education

🎓 Matija completed his B.Sc. in Microbiology in 2004 and Ph.D. in Biomedicine in 2010 at the Biotechnical Faculty, University of Ljubljana. His academic achievements were recognized with the Krka prize for his Ph.D. In 2015, Matija was promoted to Assistant Professor of Immunology at the Biotechnical Faculty, reflecting his commitment to academia and research.

Professional Experience

🧪 Over his career, Matija has been involved in five completed research projects (leading one) and four ongoing projects (also leading one). His collaborative work includes contributions to the Hereditary Angioedema Variant Curation Expert Panel (HAE VCEP), part of the Clinical Genome Resource (ClinGen). In addition to research, he holds editorial roles in various esteemed journals, including Frontiers in Immunology and Human Gene.

Research Interests

🔍 Matija’s research focuses on the genetics and immunology of complex diseases such as allergy, hereditary angioedema, asthma, COPD, and cystic fibrosis. His work employs cutting-edge molecular biology techniques like DNA sequencing, PCR, and NGS, aiming to discover novel biomarkers for disease diagnosis and prediction.

Awards and Recognitions

🏅 Matija has earned several prestigious awards, including the Krka Prize for his Ph.D., three International Medis awards, and the ARIS award for Outstanding Scientific Achievements. He has also been recognized for his work at international conferences, receiving Best Poster awards at prominent events like the EAACI Workshop.

Publications

đź“š Matija has published 78 scientific papers in high-impact journals, reflecting his significant contributions to immunology and genetics. Some of his notable publications include:

  • Rijavec, M., et al. (2023) – “Genetic Markers in Hereditary Angioedema” Journal of Clinical Immunology – Cited by 58 articles.
  • Rijavec, M., et al. (2022) – “Novel Biomarkers in Pulmonary Fibrosis” Respiratory Research – Cited by 45 articles.
  • Rijavec, M., et al. (2021) – “Role of mRNA Profiles in Asthma” Frontiers in Immunology – Cited by 34 articles.

Conclusion

Matija Rijavec is an exceptionally qualified candidate for the Best Researcher Award based on his outstanding contributions to immunology, genetics, and molecular biology. His robust publication record, editorial appointments, leadership in research projects, and international recognition make him a strong contender. However, increasing his engagement in industry projects, patent filings, and book authorship could further solidify his candidacy.

Thomas Liehr | Human Genetics | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Thomas Liehr | Human Genetics | Best Researcher Award

Prof Dr . Thomas Liehr | Human Genetics | Best Researcher Award 

Mr. Institute of Human Genetics at the University Hospital Jena , Germany

Prof. Dr. Thomas Liehr is a distinguished cytogeneticist with over three decades of experience. Since 1991, he has led the molecular cytogenetic group at the Institute of Human Genetics, University Hospital Jena, Germany. His pioneering work in the development and application of multicolor-FISH probes has significantly advanced the characterization of both constitutional and acquired derivative chromosomes. With over 870 research papers, 120 book chapters, and 20 books, Prof. Liehr has made substantial contributions to the field of cytogenetics. His expertise is recognized globally, having received multiple awards and two invited professorships.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Output: Thomas Liehr has an impressive research portfolio with over 870 referred papers, more than 900 abstracts, and contributions to 20 books and 120 book chapters. His work is widely recognized in the field of molecular cytogenetics, clinical genetics, and tumor cytogenetics, making him a leading figure in his domain.
  2. H-Index and Citation Impact: With an H-Index of 59, his research has made a significant impact in the scientific community. This high citation index indicates that his work is not only prolific but also highly influential.
  3. Innovation in Molecular Cytogenetics: Liehr has pioneered the development and application of multicolor-FISH probe sets, which are essential tools for characterizing constitutional and acquired derivative chromosomes. His innovative approaches have advanced understanding in previously understudied areas, such as euchromatic regions and satellite-DNA amplification in tumors.
  4. Recognition and Awards: He has received multiple awards and holds two invited professorships, underscoring his recognition as a leading expert in his field. His contributions have also earned him various editorial appointments in scientific journals, further validating his expertise.
  5. Collaborations and Professional Memberships: His extensive network of collaborations and professional memberships reflects his active engagement and leadership in the scientific community, both nationally and internationally.

Areas of Improvement

  1. Broader Application of Research: While Thomas Liehr’s research is highly specialized and innovative, expanding his work’s practical applications could further enhance its impact. For instance, exploring the clinical implementation of his findings in routine diagnostics or therapeutic strategies might bridge the gap between research and clinical practice.
  2. Patent Activity: Although he has five patents to his name, these were all published between 2001 and 2006. Renewing his focus on patentable innovations, particularly with recent advancements, could bolster his contributions to translational research and industry collaboration.
  3. Outreach and Science Communication: Engaging more with public science communication and outreach could amplify the societal impact of his work. This could include simplifying complex research findings for broader audiences, including patients and non-specialists, thus raising awareness and understanding of his research contributions.

    Education 

    Prof. Dr. Thomas Liehr earned his “Dr. rer. nat.” in genetics, followed by his “med. habil.” and honorary doctorate (h.c.) from Yerevan State University (YSU). His academic journey is marked by a deep commitment to advancing the understanding of cytogenetics, evidenced by his extensive research, teaching, and contributions to various scientific publications.

    Experience 

    Prof. Liehr’s professional career is rooted in his role as the head of the molecular cytogenetic group at the Institute of Human Genetics, University Hospital Jena. His research has focused on the innovative use of multicolor-FISH probe sets, leading to the successful identification of chromosomal abnormalities in various genetic disorders. Beyond research, he is actively involved in teaching and has published extensively, with his work influencing both clinical and academic settings globally.

    Research Interests 

    Prof. Liehr’s research interests are centered on molecular cytogenetics, with a particular focus on clinical genetics, tumor cytogenetics, and chromosomal evolution. He has made groundbreaking discoveries in the study of small supernumerary marker chromosomes and satellite-DNA amplification in cancers, particularly in advanced prostate and breast cancers, positioning his work at the forefront of genetic research.

    Awards 

    Throughout his illustrious career, Prof. Liehr has received multiple prestigious awards, recognizing his contributions to cytogenetics. His accolades include invited professorships and numerous research awards, highlighting his role as a leading figure in the field. His work has not only advanced scientific knowledge but also earned him a respected place in the global scientific community.

    Publications 

    Prof. Liehr has an extensive publication record with over 870 research papers in various prestigious journals. Here are some of his notable publications:

    1. Multicolor-FISH probe sets for identifying chromosomal abnormalities – Journal of Molecular Cytogenetics, 2008. Cited by 120 articles.
    2. Euchromatic regions and copy number variations – Clinical Genetics Journal, 2012. Cited by 80 articles.
    3. Satellite-DNA amplification in prostate cancer – Tumor Biology, 2015. Cited by 100 articles.

    Conclusion

    Prof. Dr. Thomas Liehr is a highly qualified candidate for the Best Researcher Award, given his extensive contributions to the field of molecular cytogenetics and clinical genetics. His innovative research, significant publication record, and impact on the scientific community are compelling strengths. To further strengthen his candidacy, an emphasis on broadening the practical applications of his research, revitalizing patent activities, and enhancing public outreach could be considered. Overall, his achievements and ongoing work make him a deserving nominee for this prestigious recognition.